Veraxa Biotech AG (VRXA)

NASDAQ: VRXA · Real-Time Price · USD

1.475

+0.005 (0.34%)

At close: Sep 18, 2026, 4:00 PM EDT

1.460

-0.015 (-1.02%)

After-hours: Sep 18, 2026, 4:10 PM EDT

Veraxa Biotech AG Balance Sheet

Financials in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Equivalents	1.61	5.36	11.35
Cash & Short-Term Investments	1.61	5.36	11.35
Cash Growth	-69.90%	-52.76%	-
Other Receivables	1.17	0.17	0.26
Receivables	1.17	0.17	0.26
Prepaid Expenses	0.1	0.07	0.27
Total Current Assets	2.88	5.61	11.88
Property, Plant & Equipment	3.11	2.83	2.13
Goodwill	22.85	22.85	22.85
Other Intangible Assets	51.91	53.49	55.08
Other Long-Term Assets	0.07	-	-
Total Assets	80.82	84.77	91.94

Liabilities

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Accounts Payable	1.39	0.49	0.61
Accrued Expenses	0.95	0.37	0.5
Current Portion of Leases	0.26	0.16	-
Current Income Taxes Payable	0.54	0.43	0.39
Other Current Liabilities	3.48	1.1	0.1
Total Current Liabilities	6.61	2.55	1.61
Long-Term Leases	0.88	0.71	-
Long-Term Deferred Tax Liabilities	14.44	15.17	15.79
Other Long-Term Liabilities	74.65	35.29	19.41
Total Liabilities	96.59	53.71	36.81

Shareholders' Equity

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Common Stock	14.75	14.18	13.41
Additional Paid-In Capital	68.25	48.96	-
Retained Earnings	-98.48	-31.86	-3.73
Comprehensive Income & Other	-0.29	-0.22	45.45
Shareholders' Equity	-15.77	31.05	55.13
Total Liabilities & Equity	80.82	84.77	91.94

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Total Debt	1.14	0.86	-
Net Cash (Debt)	0.47	4.5	11.35
Net Cash Growth	-89.48%	-60.38%	-
Net Cash Per Share	0.03	0.32	0.83
Filing Date Shares Outstanding	14.75	14.18	13.73
Total Common Shares Outstanding	14.75	14.18	13.73
Working Capital	-3.73	3.06	10.27
Book Value Per Share	-1.07	2.19	4.02
Tangible Book Value	-90.52	-45.28	-22.8
Tangible Book Value Per Share	-6.14	-3.19	-1.66
Machinery	3.2	2.99	2.87
Construction In Progress	0.01	0.01	0.01
Leasehold Improvements	0.21	-	-

SEC Filings: 10-K · 10-Q